|
|
Article: Ciprofloxacin-resistant gonorrhea on the rise.
- Article from:
- Contraceptive Technology Update
- Article date:
- June 1, 2002
CopyrightCOPYRIGHT 2002 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Ciprofloxacin-resistant gonorrhea on the rise
Recent increases in the number of gonorrhea cases resistant to fluoroquinolone antibiotics, which include ciprofloxacin, ofloxacin, and levofloxacin, are spurring fears that these antibiotics eventually may lose their effectiveness as a frontline treatment for the sexually transmitted disease (STD).
According to the Atlanta-based Centers for Disease Control and Prevention (CDC), each year approximately 650,000 people in the United States are infected with Neisseria gonorrhoeae, a gram-negative diplococcus. Ciprofloxacin has been an inexpensive treatment option for treatment of the STD; however, recent ...